Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Participants With Alzheimer's Disease

ClinicalTrials.gov ID: NCT01584440

Public ClinicalTrials.gov record NCT01584440. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 2:20 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-dummy, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety and Tolerability of AVP-923 (Dextromethorphan/Quinidine) for the Treatment of Symptoms of Agitation in Patients With Alzheimer's Disease.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objectives of the study are to evaluate the safety, tolerability and efficacy of AVP-923 compared to placebo, for the treatment of symptoms of agitation in participants with Alzheimer's Disease (AD).

Study identification

NCT ID
NCT01584440
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Avanir Pharmaceuticals
Industry
Enrollment
220 participants

Conditions and interventions

Eligibility (public fields only)

Age range
50 Years to 90 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 13, 2012 (Actual)
Primary completion
Jul 30, 2014 (Actual)
Completion
Jul 30, 2014 (Actual)
Last update posted
Nov 26, 2021

2012 – 2014

United States locations

U.S. sites
44
U.S. states
14
U.S. cities
39
Facility City State ZIP Site status
Not listed Phoenix Arizona 85006 —
Not listed Sun City Arizona 85351 —
Not listed Fresno California 93720 —
Not listed Fullerton California 92835 —
Not listed Los Angeles California 90073 —
Not listed Los Angeles California 90095 —
Not listed San Diego California 92103 —
Not listed San Francisco California 94109 —
Not listed Sherman Oaks California 91403 —
Not listed Temecula California 92591 —
Not listed Boynton Beach Florida 33426 —
Not listed Deerfield Beach Florida 33064 —
Not listed Hialeah Florida 33012 —
Not listed Miami Florida 33122 —
Not listed Miami Florida 33137 —
Not listed Miami Florida 33173 —
Not listed Ocala Florida 34471 —
Not listed Orlando Florida 32806 —
Not listed Sunrise Florida 33351 —
Not listed Tampa Florida 33609 —
Not listed West Palm Beach Florida 33407 —
Not listed West Palm Beach Florida 33409 —
Not listed Weston Florida 33331 —
Not listed Elk Grove Village Illinois 60007 —
Not listed Las Vegas Nevada 89106 —
Not listed Las Vegas Nevada 89147 —
Not listed Summit New Jersey 07902 —
Not listed Toms River New Jersey 08757 —
Not listed Orangeburg New York 10962 —
Not listed Rochester New York 14620 —
Not listed White Plains New York 10605 —
Not listed Centerville Ohio 45459 —
Not listed Cincinnati Ohio 45227 —
Not listed Cleveland Ohio 44195 —
Not listed Columbus Ohio 43221 —
Not listed Lakewood Ohio 44107 —
Not listed Allentown Pennsylvania 18104 —
Not listed Reading Pennsylvania 19604 —
Not listed Charleston South Carolina 29401 —
Not listed Houston Texas 77030 —
Not listed San Antonio Texas 78238 —
Not listed Salt Lake City Utah 84106 —
Not listed Bennington Vermont 05201 —
Not listed Spokane Washington 99204 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01584440, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 26, 2021 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01584440 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →